- Citi Mortgage Reveals Something the US Treasury Won't
- Fed Sanguine About US Recovery, Worried on Jobs
- Amended Berkshire Filing Reveals No 'Secret' Holdings
- In Time for Holidays: More Gloom and Doom on Economy
- Turkey Day 101: How Well Do You Know Your Bird?
- Privately Held Facebook Creates Dual-Class Stock
- Holiday Guide to This Season's Smartphones
- Six Ways to Boost Your Income in a Big Way
- Gambling Drunk, Eggos on eBay & More: Your Emails
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
- 3D's Tipping Point and Your Living Room
MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- GM's Agreement to Sell Saab To Swedish Firm Falls Apart
- CNBC Anchor Takes a Sabbatical
- Privately Held Facebook Creates Dual-Class Stock
- Buyers Look For Bargains At Luxury Condo Auction
- NBA D-League On The Rise
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Just In Time for Holidays: More Gloom and Doom on Economy
- Behind The Scenes With Warren Buffett
- On Twitter, Beware False Prophets
Text Size 
New York Attorney General Andrew Cuomo and 14 other states are filing a lawsuit against Amgen, alleging that the biotech company was offering kickbacks to medical providers to increase the sales of its anemia drug Aranesp.
 |
According to the complaint, Amgen, along with International Nephrology Network and ASD Healthcare, encouraged medical providers to bill third-party payers, such as Medicaid, to receive Aranesp for free.
Amgen [AMGN
Loading...
()
] was further accused of conspiring with the companies to offer medical providers weekend retreats and other services to persuade them to buy and prescribe the drug.
"Drugs should be prescribed to patients on the basis of need, effectiveness and safety, not on a corporate giant's promise of an all-expense paid vacation," Cuomo said in a press release.
The complaint said the companies allegedly caused thousands of ineligible claims for the drug to be paid and millions of dollars in damages to state Medicaid programs.
The other states involved in the complaint include California, Delaware, the District of Columbia, Florida, Hawaii, Illinois, Indiana, Louisiana, the Commonwealth of Massachusetts, Michigan, Nevada, New Hampshire, New York, Tennessee and Virginia.
Aranesp is an anemia drug that is designed to boost the production of red blood cells in the body. It was approved by the FDA in 2001. Amgen's total revenue since the drug has been on the market totals more than $11 billion.
Amgen shares were down in afternoon trading.
- Remember when auto shows were major events where new models could generate buzz?
- CNBC’s Mike Huckman visits a cutting-edge plant to see how the flu vaccine of the future is being made.
- People who bottle up their anger at work are up to five times more likely to suffer a heart attack, a study found.
- Playboy will outsource its publishing operations in a bid to become profitable again.
- A new McDonald's in Manhattan is the nation's first to sport a sleek, chic interior imported from stores in London and Paris.
- For nearly three decades, these on-call experts have been dishing advice on how to – and not to – cook turkey.
Data is a real-time snapshot *Data is delayed at least 15 minutes